These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7125622)

  • 1. [Circulation of ampicillin and sulfalene in liver disease patients].
    Iakovlev VP; Bobrov VI; Gal'perin EI; Volkova NV; Nazarova OI
    Antibiotiki; 1982 Aug; 27(8):619-23. PubMed ID: 7125622
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacokinetics of sulfalene and sulfamethoxine after combined administration with benzylpenicillin and ampicillin].
    Bobrov VI; Nazarova OI; Agapitova IV; Kalenik NM; Iakovlev VP
    Antibiotiki; 1984 Apr; 29(4):277-82. PubMed ID: 6742805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sulfalene circulation in kidney disease patients].
    Iakovlev VP; Bobrov VI; Rudzit EA; Ermole nko VM; Zaslavskaia RM
    Antibiotiki; 1981 Mar; 26(3):136-9. PubMed ID: 7235658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sulfalene kinetics in the blood and cerebrospinal fluid in arachnoiditis].
    Geĭtman IIa; Kardash BE; Kivman GIa
    Farmakol Toksikol; 1982; 45(4):83-5. PubMed ID: 7128796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Distribution of sulfanilamides and penicillins in the blood and organs of rats after their combined administration].
    Bobrov VI; Beletskaia GT
    Antibiotiki; 1984 Dec; 29(12):913-6. PubMed ID: 6524894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetic characteristics of 2-sulfamilamido-3-methoxypyrazine. Blood and tissue levels in patients undergoing surgical operations].
    Calabi V; Moretti A; Vannini E; Bini A; Pepe G
    Atti Accad Med Lomb; 1973; 28(1-4):69-74. PubMed ID: 4807502
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmacokinetics and the clinical use of sulfalene].
    Aleksa VI; Prozorova VK
    Sov Med; 1985; (10):106-8. PubMed ID: 4081844
    [No Abstract]   [Full Text] [Related]  

  • 8. [Sulfanilamide absorption and acetylation in rats with experimental hyperlipidemia and cellular regulation of the process of acetylation].
    Makarov VA; Vasilenko IuK; Suetina IV; Vaskanian VL; Lubiankina SV
    Farmakol Toksikol; 1981; 44(1):109-15. PubMed ID: 6266869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Metabolic disturbances in chronic diseases of the biliary tracts and liver].
    Kozlovskiĭ IV; Okorokov AN
    Vrach Delo; 1982 Aug; (8):22-4. PubMed ID: 6755904
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacodynamics of cephaloridine and cephalothin combined with sulfalene in rabbits].
    Bobrov VI; Beletskaia GT; Iakovlev VP
    Antibiotiki; 1984 Nov; 29(11):823-5. PubMed ID: 6524880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Metabolic capacity of the liver for drugs in hepatobiliary patients].
    González Macias J; Herreros Fernández V; De Castro Del Pozo S
    Rev Clin Esp; 1975 Jan; 136(2):123-30. PubMed ID: 1121588
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetic study of a sulfametopyrazine/trimethoprim combination (Kelfiprim) in human volunteers.
    Reeves DS; Bywater MJ; Bullock DW; Holt HA
    J Antimicrob Chemother; 1980 Sep; 6(5):647-56. PubMed ID: 7410285
    [No Abstract]   [Full Text] [Related]  

  • 13. [Bile electrolytes in patients with chronic diseases of the liver and bile ducts].
    Revutskiĭ BI; Shmakov VN; Nechaev EN
    Vrach Delo; 1969 Oct; 10():118-20. PubMed ID: 5366772
    [No Abstract]   [Full Text] [Related]  

  • 14. [Characteristics of the distribution of long-acting sulfanilamides in purulent pyelonephritis in rats].
    Rudzit EA; Ostapchuk NV; Bobrov VI
    Antibiotiki; 1983 Nov; 28(11):837-41. PubMed ID: 6651273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum levels and urinary excretion of trimethoprim and sulfamethoxypyrazine after combined administration in man].
    De Pascale V; Craveri F; Crema A; Dormia Cristallo L; Saglia G
    Farmaco Prat; 1977 May; 32(5):228-37. PubMed ID: 862874
    [No Abstract]   [Full Text] [Related]  

  • 16. [Activity of angiotensin converting enzyme I and levels of acid alpha glycoprotein in selected liver and biliary tract diseases].
    Podwysocki B; Simon K; Gładysz A
    Pol Tyg Lek; 1993 Mar 15-29; 48(11-13):268-70. PubMed ID: 8234040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetics of sulfachlorpyridazine].
    Mariño EL; Tabernero JM; Macías JG; Domínguez-Gil A; de Castro S
    Arch Farmacol Toxicol; 1979 Apr; 5(1):57-71. PubMed ID: 475478
    [No Abstract]   [Full Text] [Related]  

  • 18. Distribution of trimethoprim and sulfametopyrazine in the female reproductive tract.
    Preza PC; Moura C; Leite Filho A; Cavallari V; Nüdemberg F; Piaia F
    J Int Med Res; 1986; 14(2):101-4. PubMed ID: 3699239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical trial of injectable ampicillin in hepato-biliary diseases in particular].
    Fraisse H; Etaix JP
    Lyon Med; 1966 Jan; 215(5):271-7. PubMed ID: 5909728
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacokinetics of benzylpenicillin and ampicillin in patients after combined administration with sulfalen and sulfadimethoxine].
    Bobrov VI; Olevskiĭ IKh; Segel'man VS; Iakovlev VP
    Antibiot Med Biotekhnol; 1987 May; 32(5):385-8. PubMed ID: 3606058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.